GSK terminates collaboration with Alector after trial failures
Go back to GSK terminates collaboration with Alector after trial failures| (NASDAQ: ALEC) | Delayed: 2.02 +0.19 (10.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $ | |||
| Open | $1.82 | 52 Week Low | $ | |||
| Day High | $2.02 | P/E | N/A | |||
| Day Low | $1.82 | EPS | $ | |||
| Volume | 1,244,655 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.06 -0.04 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.10 | 52 Week High | $45.58 | |||
| Open | $50.80 | 52 Week Low | $37.82 | |||
| Day High | $51.25 | P/E | N/A | |||
| Day Low | $50.64 | EPS | $0.00 | |||
| Volume | 1,212,922 | |||||



